Status: current, Defined. Date: 31-May 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2381631000168117 | hyaluronic acid 20 mg / 1 mL injection, 3 mL syringe (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2381641000168114 | hyaluronic acid 20 mg/mL injection, 3 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| hyaluronic acid 20 mg/mL injection, 3 mL syringe | Is a | hyaluronic acid | true | Inferred relationship | Some | ||
| hyaluronic acid 20 mg/mL injection, 3 mL syringe | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| hyaluronic acid 20 mg/mL injection, 3 mL syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| hyaluronic acid 20 mg/mL injection, 3 mL syringe | has unit of use | syringe | true | Inferred relationship | Some | 600895505 | |
| hyaluronic acid 20 mg/mL injection, 3 mL syringe | has intended active ingredient | hyaluronic acid | true | Inferred relationship | Some | 600895504 | |
| hyaluronic acid 20 mg/mL injection, 3 mL syringe | has Australian BoSS | hyaluronic acid | true | Inferred relationship | Some | 600895504 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| hyaluronic acid 20 mg/mL injection, 3 mL syringe | has MPUU | True | hyaluronic acid 20 mg/mL injection, 3 mL syringe | Inferred relationship | Some | 1 |
| Durolane (hyaluronic acid 20 mg / 1 mL) injection, 3 mL syringe (trade product unit of use) | Is a | True | hyaluronic acid 20 mg/mL injection, 3 mL syringe | Inferred relationship | Some |
Reference Sets
Medicinal product unit of use reference set
FHIR